Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains
Marc James Quesnel(Douglas Mental Health University Institute), Miriam T. Ashford, Juliet Fockler, Richard J. Perrin(Washington University in St. Louis), Ann Brinkmalm(Sahlgrenska University Hospital), Nina Silverberg(Banner Sun Health Research Institute), John Q. Trojanowki(University of Southern California), Kaj Blennow(Sahlgrenska University Hospital), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Lisa L. Barnes(Rush University Medical Center), Marie Bernard, Judes Poirier(Douglas Mental Health University Institute), John Hsiao(National Institute on Aging), Jonathan Jackson(Harvard University), Ronald C. Petersen(Mayo Clinic in Arizona), Maria Carrillo, Diana Truran Sacrey, Chengshi Jin(University of California, San Francisco), Anne Labonté, William J. Jagust(Lawrence Berkeley National Laboratory), Cynthia Picard, Héctor Alfredo Baptista González, Eliezer Masliah(University of California San Diego), Cat Conti, Rachel L. Nosheny(University of California, San Francisco), Henrik Zetterberg(University of Wisconsin–Madison), Sylvia Villeneuve(Douglas Mental Health University Institute), Donna Masterman(University of California, Los Angeles), Beckett Ls, Zaven S. Khachaturian(University of Southern California), Dallas P. Veitch, Ozioma C. Okonkwo(University of Wisconsin–Madison), Laurie Ryan(Alzheimer's Association), William Z. Potter(United States Military Academy), Carole Ho, John C Morris, Adam Fleisher, Michael W Weiner, Paul Aisen, for the Alzheimer’s Disease Neuroimaging Initiative, Arthur W Toga, Leslie M Shaw, Ronald Petersen, Clifford R. Jack(Mayo Clinic), Robert C Green, John Neuhaus(Max Planck Research Unit for Neurogenetics)
Cited by 21
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k